|
|
胃肠间质瘤恶性程度的影响因素研究
|
Abstract:
胃肠间质瘤(GISTs)是一种起源于消化道的稀有肿瘤，其恶性程度对患者的预后和治疗方案具有重要影响。近年来，随着分子生物学和肿瘤学的发展，研究者们逐渐认识到多种因素在GISTs的恶性程度中扮演着重要角色，包括基因突变、肿瘤大小、组织学特征等。然而，目前关于这些因素在GISTs恶性程度中的具体作用机制及其相互关系的研究仍然存在不少争议和不足。本文旨在综合分析目前的研究成果，探讨影响胃肠间质瘤恶性程度的相关因素，并通过回顾近年来的相关文献，提出对临床实践的启示与未来研究的方向，从而为GISTs的早期诊断和个性化治疗提供理论依据。
Gastrointestinal stromal tumors (GISTs) are rare neoplasms originating from the digestive tract, and their malignant potential significantly impacts patient prognosis and treatment strategies. In recent years, with advances in molecular biology and oncology, researchers have increasingly recognized that multiple factors play crucial roles in determining the malignancy of GISTs, including genetic mutations, tumor size, and histological characteristics. However, current understanding of the precise mechanisms and interrelationships of these factors in GIST malignancy remains controversial and incomplete. This article aims to comprehensively analyze existing research findings, explore the factors influencing the malignant potential of GISTs, and review recent relevant literature to provide insights for clinical practice and future research directions. The ultimate goal is to establish a theoretical foundation for the early diagnosis and personalized treatment of GISTs.
| [1] | Jaros, D., Bozic, B. and Sebesta, C. (2022) Gastrointestinale Stromatumoren (GIST). Wiener Medizinische Wochenschrift, 173, 201-205. https://doi.org/10.1007/s10354-022-00965-8 |
| [2] | Watson, S. and Bonnet, C. (2024) Prise en charge des tumeurs stromales gastro-intestinales [Management of Gastrointestinal Stromal Tumors]. La Revue du Praticien, 74, 537-541. |
| [3] | Gheorghe, G., Bacalbasa, N., Ceobanu, G., Ilie, M., Enache, V., Constantinescu, G., et al. (2021) Gastrointestinal Stromal Tumors—A Mini Review. Journal of Personalized Medicine, 11, Article No. 694. https://doi.org/10.3390/jpm11080694 |
| [4] | Ravegnini, G., Hrelia, P. and Angelini, S. (2019) Somatic Pharmacogenomics of Gastrointestinal Stromal Tumor. Cancer Drug Resistance, 2, 107-115. https://doi.org/10.20517/cdr.2019.02 |
| [5] | Wang, Y. and Call, J. (2019) Mutational Testing in Gastrointestinal Stromal Tumor. Current Cancer Drug Targets, 19, 688-697. https://doi.org/10.2174/1568009619666190326123945 |
| [6] | 贺慧颖, 方伟岗, 钟镐镐. 165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J]. 中华病理学杂志, 2006(5): 262-266. |
| [7] | Kalfusova, A., Linke, Z., Kalinova, M., Krskova, L., Hilska, I., Szabova, J., et al. (2019) Gastrointestinal Stromal Tumors—Summary of Mutational Status of the Primary/Secondary KIT/PDGFRA Mutations, BRAF Mutations and SDH Defects. Pathology—Research and Practice, 215, Article ID: 152708. https://doi.org/10.1016/j.prp.2019.152708 |
| [8] | Wang, S., Zhang, Q., Wu, H., Yang, Z., Guo, X., Wang, F., et al. (2021) Mutations of the C-Kit and PDGFRA Gene in Gastrointestinal Stromal Tumors among Hakka Population of Southern China. Nigerian Journal of Clinical Practice, 24, 814-820. https://doi.org/10.4103/njcp.njcp_582_19 |
| [9] | 童昕, 王涛, 黄永周. 胃的胃肠间质瘤患者基因突变状态及预后分析[J]. 肿瘤, 2022, 42(10): 673-680. |
| [10] | Serrano, C., Bauer, S., Gómez-Peregrina, D., Kang, Y., Jones, R.L., Rutkowski, P., et al. (2023) Circulating Tumor DNA Analysis of the Phase III VOYAGER Trial: KIT Mutational Landscape and Outcomes in Patients with Advanced Gastrointestinal Stromal Tumor Treated with Avapritinib or Regorafenib. Annals of Oncology, 34, 615-625. https://doi.org/10.1016/j.annonc.2023.04.006 |
| [11] | Vitiello, G.A., Bowler, T.G., Liu, M., Medina, B.D., Zhang, J.Q., Param, N.J., et al. (2019) Differential Immune Profiles Distinguish the Mutational Subtypes of Gastrointestinal Stromal Tumor. Journal of Clinical Investigation, 129, 1863-1877. https://doi.org/10.1172/jci124108 |
| [12] | Khan, A.A., Liu, X., Yan, X., Tahir, M., Ali, S. and Huang, H. (2021) An Overview of Genetic Mutations and Epigenetic Signatures in the Course of Pancreatic Cancer Progression. Cancer and Metastasis Reviews, 40, 245-272. https://doi.org/10.1007/s10555-020-09952-0 |
| [13] | Padda, J., Khalid, K., Yadav, J., Almanie, A.H., Mehta, K.A., Al Hennawi, H., et al. (2021) JAK2 and TET2 Mutation in Polycythemia Vera. Cureus, 13, e17854. https://doi.org/10.7759/cureus.17854 |
| [14] | Snider, D.B., Arthur, G.K., Falduto, G.H., Olivera, A., Ehrhardt-Humbert, L.C., Smith, E., et al. (2022) Targeting KIT by Frameshifting mRNA Transcripts as a Therapeutic Strategy for Aggressive Mast Cell Neoplasms. Molecular Therapy, 30, 295-310. https://doi.org/10.1016/j.ymthe.2021.08.009 |
| [15] | Ma, R., Liu, Z., Cheng, Y., Zhou, P., Pan, Y., Bi, H., et al. (2022) Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. European Urology Open Science, 42, 19-29. https://doi.org/10.1016/j.euros.2022.06.001 |
| [16] | Mimae, T., Tsutani, Y., Miyata, Y., Imai, K., Ito, H., Nakayama, H., et al. (2020) Solid Tumor Size of 2 cm Divides Outcomes of Patients with Mixed Ground Glass Opacity Lung Tumors. The Annals of Thoracic Surgery, 109, 1530-1536. https://doi.org/10.1016/j.athoracsur.2019.12.008 |
| [17] | 潘志忠, 伍小军, 姜武. 胃肠间质瘤分子分型的临床实践价值[J]. 中华外科杂志, 2014, 17(4): 317-320. |
| [18] | 曾卓辉, 林岗, 赵振军. 胃肠间质瘤CT表现及预测肿瘤恶性程度分析[J]. 中国CT和MRI杂志, 2017, 15(1): 101-103. |
| [19] | Liang, B., Gu, J., Xiong, M., Zhang, E., Zhang, Z., Chen, X., et al. (2021) Tumor Size May Influence the Prognosis of Solitary Hepatocellular Carcinoma Patients with Cirrhosis and without Macrovascular Invasion after Hepatectomy. Scientific Reports, 11, Article No. 16343. https://doi.org/10.1038/s41598-021-95835-5 |
| [20] | Pang, T., Zhao, Y., Fan, T., Hu, Q., Raymond, D., Cao, S., et al. (2019) Comparison of Safety and Outcomes between Endoscopic and Surgical Resections of Small (≤5 cm) Primary Gastric Gastrointestinal Stromal Tumors. Journal of Cancer, 10, 4132-4141. https://doi.org/10.7150/jca.29443 |
| [21] | 中国临床肿瘤学会指南工作委员会组织. 中国临床肿瘤学会(CSCO)胃肠间质瘤诊疗指南-2023 [M]. 北京: 人民卫生出版社, 2023. |
| [22] | 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)胃肠间质瘤诊疗指南2024 [M]. 北京: 人民卫生出版社, 2024: 44-65. |
| [23] | Kim, G.H. (2022) Systematic Endoscopic Approach for Diagnosing Gastric Subepithelial Tumors. Gut and Liver, 16, 19-27. https://doi.org/10.5009/gnl20296 |
| [24] | Sharzehi, K., Sethi, A. and Savides, T. (2022) AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered during Routine Endoscopy: Expert Review. Clinical Gastroenterology and Hepatology, 20, 2435-2443.e4. https://doi.org/10.1016/j.cgh.2022.05.054 |
| [25] | Polkowski, M. (2005) Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Biopsy for the Diagnosis of Malignant Submucosal Tumors. Endoscopy, 37, 635-645. https://doi.org/10.1055/s-2005-861422 |
| [26] | 陶怡, 王威东, 谢芳, 等. 胃间质瘤超声内镜特征与术前恶性潜能评估的相关性研究[J]. 中国社区医师, 2023, 39(22): 72-75. |
| [27] | 李吉友, 等. 胃肠间质瘤病理诊断规范[J]. 中国肿瘤临床, 2019, 46(15): 769-774. |
| [28] | 张祥宏, 等. 胃肠间质瘤分子病理特征与临床治疗选择[J]. 中华胃肠外科杂志, 2020, 23(4): 325-330. |
| [29] | Miettinen, M., et al. (2022) Gastrointestinal Stromal Tumors: Pathology and Prognosis at Different Sites. Modern Pathology, 35, 1-12. |
| [30] | Pih, G.Y., Jeon, S.J., Ahn, J.Y., Na, H.K., Lee, J.H., Jung, K.W., et al. (2019) Clinical Outcomes of Upper Gastrointestinal Bleeding in Patients with Gastric Gastrointestinal Stromal Tumor. Surgical Endoscopy, 34, 696-706. https://doi.org/10.1007/s00464-019-06816-9 |
| [31] | 王振华, 梁小波. 胃肠道间质瘤流行病学研究进展[J]. 国际流行病学传染病学杂志, 2013, 40(3): 211-214. |
| [32] | Calabrò, A., Accardi, G., Aiello, A., Caruso, C. and Candore, G. (2023) Sex and Gender Affect Immune Aging. Frontiers in Aging, 4, Article ID: 1272118. https://doi.org/10.3389/fragi.2023.1272118 |
| [33] | Oertelt-Prigione, S. (2021) Why We Need Ageing Research Sensitive to Age and Gender. The Lancet Healthy Longevity, 2, e445-e446. https://doi.org/10.1016/s2666-7568(21)00149-5 |
| [34] | Patel, G.B. and Peters, A.T. (2019) Comorbidities Associated with Severe Asthma. Journal of Precision Respiratory Medicine, 2, 5-9. https://doi.org/10.2500/jprm.2019.190006 |
| [35] | Cazzola, M., Rogliani, P., Ora, J., Calzetta, L. and Matera, M.G. (2023) Cardiovascular Diseases or Type 2 Diabetes Mellitus and Chronic Airway Diseases: Mutual Pharmacological Interferences. Therapeutic Advances in Chronic Disease, 14, Article ID: 20406223231171556. https://doi.org/10.1177/20406223231171556 |
| [36] | Santiago, J.A. and Potashkin, J.A. (2021) The Impact of Disease Comorbidities in Alzheimer’s Disease. Frontiers in Aging Neuroscience, 13, Article ID: 631770. https://doi.org/10.3389/fnagi.2021.631770 |
| [37] | Capobianco, E. and Dominietto, M. (2023) Assessment of Brain Cancer Atlas Maps with Multimodal Imaging Features. Journal of Translational Medicine, 21, Article No. 385. https://doi.org/10.1186/s12967-023-04222-3 |
| [38] | Varga, D. (2021) No-Reference Image Quality Assessment with Global Statistical Features. Journal of Imaging, 7, Article No. 29. https://doi.org/10.3390/jimaging7020029 |
| [39] | Feng, C., Ye, L. and Zhang, Q. (2022) Cross-Domain Feature Similarity Guided Blind Image Quality Assessment. Frontiers in Neuroscience, 15, Article ID: 767977. https://doi.org/10.3389/fnins.2021.767977 |
